.Amgen has shared (PDF) the 1st stage 3 information on its $400 million chronic eczema drug, linking...
.Biogen and also UCB's bet one's bottom dollar developing into stage 3 astride a failed study aims t...
.Italian biotech Aptadir Therapies has released with the assurance that its pipeline of preclinical ...
.Wave Life Sciences has actually fulfilled its target in a Duchenne muscle dystrophy (DMD) research ...
.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, occupying th...
.Achilles Therapeutics has destroyed its approach. The English biotech is actually stopping work on ...
.Aligos Therapies is advertising a midstage win in metabolic-dysfunction affiliated steatohepatitis ...
.Basilea Pharmaceutica's job developing brand new antifungals has obtained a significant improvement...
.Having presently gathered up the U.S. civil liberties to Capricor Therapies' late-stage Duchenne mu...
.After pushing back the selection meeting for Applied Rehabs' metabolic ailment medicine govorestat,...